CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | AYERS JONATHAN W Director | Sale | −2,527 | $536.43 | $1.4M | 656,174 |
| 2021-05-20 | AYERS JONATHAN W Director | Sale | −2,058 | $537.62 | $1.1M | 654,116 |
| 2021-05-20 | AYERS JONATHAN W Director | Sale | −415 | $538.18 | $223K | 653,701 |
| 2021-05-20 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −5,000 | 135,000 | ||
| 2021-05-18 | MAZELSKY JONATHAN JAY President & CEO | Gift | −500 | 55,209 | ||
| 2021-05-18 | AYERS JONATHAN W Director | Exercise or conversion | +7,632 | $79.54 | $607K | 661,333 |
| 2021-05-18 | AYERS JONATHAN W Director | Sale | −7,632 | $528.01 | $4.0M | 653,701 |
| 2021-05-18 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −7,632 | 140,000 | ||
| 2021-05-12 | AYERS JONATHAN W Director | Gift | −9,000 | 644,701 | ||
| 2021-05-12 | Vandebroek Sophie V. Director | Grant or award · Restricted Stock Unit | +224 | 224 | ||
| 2021-05-12 | Vandebroek Sophie V. Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | SZOSTAK M ANNE Director | Grant or award · Restricted Stock Unit | +224 | 224 | ||
| 2021-05-12 | SZOSTAK M ANNE Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | SAMAD SAM Director | Grant or award · Deferred Stock Unit | +224 | 887 | ||
| 2021-05-12 | SAMAD SAM Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | Kingsley Lawrence D Director | Grant or award · Restricted Stock Unit | +224 | 224 | ||
| 2021-05-12 | Kingsley Lawrence D Director | Grant or award · Restricted Stock Unit | +78 | 302 | ||
| 2021-05-12 | Kingsley Lawrence D Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +723 | 723 | ||
| 2021-05-12 | Kingsley Lawrence D Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +252 | 975 | ||
| 2021-05-12 | JUNIUS DANIEL M Director | Grant or award · Deferred Stock Unit | +224 | 3,387 |
Page 71 of 74 · 1,474 trades